Update on the role of antiseptics in the management of chronic wounds with critical colonisation and/or biofilm
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Biofilms play a major role in delaying chronic wounds from healing. A wound infiltrated with biofilm, or “critically colonised” wound, may become clinically infected if the number of microbes exceeds a critical level. Chronic wound biofilms represent a significant treatment challenge by demonstrating recalcitrance towards antimicrobial agents. However, a “window of opportunity” may exist after wound debridement when biofilms are more susceptible to topical antiseptics. Here, we discuss the role of antiseptics in the management of chronic wounds and biofilm, focusing on povidone‐iodine (PVP‐I) in comparison with two commonly used antiseptics: polyhexanide (PHMB) and silver. This article is based on the literature reviewed during a focus group meeting on antiseptics in wound care and biofilm management, and on a PubMed search conducted in March 2020. Compared with PHMB and silver, PVP‐I has a broader spectrum of antimicrobial activity, potent antibiofilm efficacy, no acquired bacterial resistance or cross‐resistance, low cytotoxicity, good tolerability, and an ability to promote wound healing. PVP‐I represents a viable therapeutic option in wound care and biofilm management, with the potential to treat biofilm‐infiltrated, critically colonised wounds. We propose a practical algorithm to guide the management of chronic, non‐healing wounds due to critical colonisation or biofilm, using PVP‐I.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Factors affecting wound healing
Guo, S., & DiPietro, L. A. (2010) · Journal of Dental Research · doi:10.1177/0022034509359125 · Cited by 5,792
PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healing
Barrientos, S., Stojadinovic, O., Golinko, M. S., Brem, H., & Tomic‐Canic, M. (2008) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2008.00410.x · Cited by 3,583
Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria
Hall, C. W., & Mah, T.-F. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux010 · Cited by 1,696
James, G. A., Swogger, E., Wolcott, R., Pulcini, E. D., Secor, P., Sestrich, J., Costerton, J. W., & Stewart, P. S. (2008) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2007.00321.x · Cited by 1,543 · cited 1×
“2%, although a more conservative estimate suggests that the figure may be 60%.(13,20) Biofilms in chronic wounds are difficult to visualise macroscopically, and whether located on the surface of a wound or deeper in the wound bed, the identification and diagnosis of biofilms in chronic wounds can be challenging.”
BackgroundThe humanistic and economic burden of chronic wounds: A systematic review
Olsson, M., Järbrink, K., Divakar, U., Bajpai, R., Upton, Z., Schmidtchen, A., & Car, J. (2019) · Wound Repair and Regeneration · doi:10.1111/wrr.12683 · Cited by 865
Nunan, R., Harding, K. G., & Martin, P. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.016782 · Cited by 542
Selection of Appropriate Wound Dressing for Various Wounds
Shi, C., Wang, C., Liu, H., Li, Q., Li, R., Zhang, Y., Liu, Y., Shao, Y., & Wang, J. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00182 · Cited by 522 · cited 3×
“Numerous types of dressing are available to both protect the wound and promote healing (Table 3).(1,164) Choosing the most appropriate option from the extensive range of dressings available can be a difficult treatment decision, but it should ultimately be tailored to the characteristics of each wound and to the patie…”
BackgroundMethodCandida auris : The recent emergence of a multidrug-resistant fungal pathogen
Forsberg, K., Woodworth, K., Walters, M., Berkow, E. L., Jackson, B., Chiller, T., & Vallabhaneni, S. (2019) · Medical Mycology · doi:10.1093/mmy/myy054 · Cited by 421 · cited 1×
“In a complex biofilm model, PVP-I 10% solution destroyed both early (90 minutes) and mature (48 hours) biofilms formed by Candida auris, an emerging multi-drug resistant yeast.(88,89) The antibiofilm efficacy of PVP-I is rapid in onset in vitro, with total eradication of mature 3-day biofilms of S aureus and P aerugin…”
BackgroundEggers, M., Koburger-Janssen, T., Eickmann, M., & Zorn, J. (2018) · Infectious Diseases and Therapy · doi:10.1007/s40121-018-0200-7 · Cited by 386
Biocidal Agents Used for Disinfection Can Enhance Antibiotic Resistance in Gram-Negative Species
Kampf, G. (2018) · Antibiotics · doi:10.3390/antibiotics7040110 · Cited by 230 · cited 1×
“In addition, no evidence of cross-resistance to antibiotics or other antiseptics has been observed with PVP-I use in a wide range of Grampositive and Gram-negative bacterial species.(40,46,47)”
BackgroundEggers, M., Eickmann, M., & Zorn, J. (2015) · Infectious Diseases and Therapy · doi:10.1007/s40121-015-0091-9 · Cited by 229
Lara, H. H., Ixtepan-Turrent, L., Jose Yacaman, M., & Lopez-Ribot, J. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b20708 · Cited by 116 · cited 1×
“Potent antibiofilm efficacy of silver nanoparticles has been shown against C auris by inhibition of biofilm formation and by the disruption and distortion of pre-formed biofilms.(106) Silver nanoparticles have demonstrated potent inhibition of biofilm formation by Escherichia coli, P aeruginosa, and Serratia proteamac…”
Background
Cited by
Bacterial Biofilm in Chronic Wounds and Possible Therapeutic Approaches
Cavallo, I., Sivori, F., Mastrofrancesco, A., Abril, E., Pontone, M., Di Domenico, E. G., & Pimpinelli, F. (2024) · Biology · doi:10.3390/biology13020109 · Cited by 213
Brożyna, M., Dudek, B., Kozłowska, W., Malec, K., Paleczny, J., Detyna, J., Fabianowska-Majewska, K., & Junka, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-52424-6 · Cited by 24
Metadata
- Authors
- Alves, P. J., Barreto, R. T., Barrois, B. M., Gryson, L. G., Meaume, S., & Monstrey, S. J.
- Venue
- International Wound Journal
- Publisher
- Wiley
- Published
- 2020-12-13
- Volume
- 18
- Issue
- 3
- Pages
- 342-358
- ISSN
- 1742-4801 (ISSN-L)
- 1742-481X
- OpenAlex
- W3113367115
- Cited by
- 117
- References
- 12
- FWCI
- 5.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.